Psoriasis vs Eczema vs Seb Derm: How to Tell Them Apart

Three of the most common red, scaly rashes get mixed up constantly — and the drugstore fix for one can actively inflame another. The tells are location, scale, and the way it itches.

25-Second Preview A quick listen to set the scene — the full story’s below.
Read the preview

Which side of your elbow is the rash on? It matters. Psoriasis favors the outside, with thick, silvery, sharp-edged plaques. Eczema sits in the inner fold — blurry, dry, fiercely itchy. Seb derm hides where skin is oiliest, with greasy yellow flakes driven by a yeast. And the drugstore fix for one can inflame another. The Dermington Gazette spots the difference.

Why these three get confused in the first place

Red. Scaly. Itchy. To the naked eye, psoriasis, eczema, and seborrheic dermatitis can all open with the same three-word description, which is exactly why they get tangled — including, sometimes, at a rushed appointment. But under that shared surface they're three genuinely different diseases with three different engines: psoriasis is immune-driven skin cells overproducing at breakneck speed, eczema is a leaky skin barrier plus an over-reactive immune response, and seborrheic dermatitis is an inflammatory reaction to a normal skin yeast.

That matters enormously the moment you reach for a product, because their treatments point in different directions. An antifungal wash that clears seb derm won't budge a psoriasis plaque. A thick occlusive balm that comforts eczema can, on an oily seb-derm-prone face, give the yeast more of the environment it thrives in. Even topical steroids — the reflexive fix for 'a rash' — help some presentations and, misused, can rebound others. So learning to read the three apart isn't dermatology trivia; it's the difference between calming your skin and quietly aggravating it.

Location is the loudest clue

Before scale or itch, look at the map. Each condition has favorite real estate, and the geography alone narrows things fast. Psoriasis classically parks on the extensor surfaces — the outsides of the elbows and knees — plus the scalp, the lower back, and the nails (look for pitting or an oil-drop discoloration). Its plaques often sit symmetrically and have a sharp, almost drawn-on border between rash and normal skin.

Eczema flips the geography: in adults and older children it favors the flexural surfaces — the soft insides of the elbows and the backs of the knees — plus the hands, eyelids, and neck, and its edges are blurry, fading into the surrounding skin rather than stopping cleanly. (In babies it's different again, often starting on the cheeks and scalp.) Seborrheic dermatitis has the most distinctive address of all: it clusters exactly where sebaceous glands are densest, the scalp, eyebrows, the creases beside the nose, behind the ears, and the mid-chest. If a flaky red patch is riding the sides of your nose and your brows, you're almost certainly looking at seb derm, not the other two. None of these maps is absolute — psoriasis can appear in skin folds, eczema can spread widely — but the favored locations are the single most useful first filter, and they're free to check in the mirror.

Scale and itch: the tie-breakers

When location leaves doubt, the texture of the scale and the character of the itch usually settle it. Psoriasis scale is thick, dry, and silvery-white, and it's loosely adherent — a classic (if you don't overdo it) sign is that picking a scale can leave pinpoint bleeding underneath, a reflection of the dilated vessels feeding that overactive skin. Psoriasis can itch, but it's often described more as soreness or burning than the frantic itch of eczema.

Eczema, by contrast, is defined by the itch — the old teaching is that it's 'the itch that rashes,' meaning the scratching often comes before the visible rash and drives it. Its scale is fine and dry, layered over red, sometimes cracked or weepy skin, on a canvas of generally dry, sensitive skin. Seborrheic dermatitis produces a different flake entirely: greasy, yellowish, and soft rather than thick and silvery, sitting on pink skin in those oily zones. Dandruff is simply seb derm's mildest scalp form, which is why an antifungal dandruff shampoo often calms it. Greasy-yellow says yeast; thick-silvery says psoriasis; dry-and-desperately-itchy says eczema. It's not foolproof, and plenty of real cases are less tidy than the textbook, but as a first pass it's remarkably good. If you're tracking an itchy, dry, flaring rash over time, our [eczema-severity] tool can help you gauge whether it's escalating.

Why the right label changes the whole treatment plan

Here's where a correct read pays off, because the three treatment paths barely overlap. Seborrheic dermatitis responds to antifungals — the evidence for topical ketoconazole and similar azoles is strong, since knocking down Malassezia calms the whole reaction. A zinc-pyrithione wash like the Vanicream Z-Bar is a gentle, effective OTC starting point for facial and scalp seb derm, working on the yeast rather than just the redness.

Eczema treatment is a two-front effort: repair the broken barrier and calm the inflammation. Fragrance-free, ceramide- and colloidal-oatmeal-rich moisturizers do the structural work — a barrier cream like Prequel Barrier Therapy or a ceramide-and-cholesterol formula like Aestura Atobarrier 365 Cream are exactly the kind of daily base that reduces flares — while prescription anti-inflammatories handle the immune side. Psoriasis is different again: because it's runaway skin-cell turnover, it often calls for vitamin D analogs (like calcipotriene), targeted topical steroids, and for stubborn or widespread disease, systemic or biologic drugs that no cream can replace. Slather a psoriasis plaque in barrier cream alone and you'll soften the scale but not touch the disease. That's the practical cost of a wrong label.

The part people miss: psoriasis isn't only skin-deep

There's one more reason getting psoriasis right specifically matters more than cosmetic clarity: it's a systemic inflammatory disease, not a surface nuisance. The same overactive inflammatory signaling that thickens the skin circulates through the body, and a substantial literature ties psoriasis — especially moderate-to-severe disease — to a raised risk of psoriatic arthritis, cardiovascular events, and metabolic conditions like diabetes and obesity. A 2018 review in Frontiers in Immunology lays out how chronically released inflammatory cytokines from poorly controlled psoriatic skin can drive insulin resistance and blood-vessel dysfunction. That reframes psoriasis from 'a rash' to 'a whole-body condition that shows up on the skin.'

Which is the honest boundary of self-treatment. Mild, localized seb derm and mild eczema are reasonable to manage at home with the right OTC tools. But a rash that's spreading, cracking and painful, not responding after a couple of weeks, appearing with joint pain, or that you simply can't confidently identify is a reason to see a professional — both to nail the diagnosis and, in psoriasis, to address the systemic picture. Our [derm-visit-prep] tool helps you photograph and describe the pattern, location, and timeline so a clinician can sort it quickly. Reading these three apart is a genuinely useful skill; knowing when reading stops and a doctor starts is the more important one.

Ingredients in this piece

Each shelf lists every product in the catalogue built on the ingredient, graded live against your profile — the shelf stays current when a single pick would not.

Products named in this piece

Independently reviewed, with a verdict per concern — the real products behind this piece.

References

  1. An Overview of the Diagnosis and Management of Seborrheic Dermatitis — Clinical, Cosmetic and Investigational Dermatology, 2022
  2. Systemic Inflammation and Cardiovascular Comorbidity in Psoriasis Patients: Causes and Consequences — Frontiers in Immunology, 2018

Every cited link is verified to resolve to the paper named. Where a source could not be independently confirmed, it is listed without a link rather than pointing you somewhere wrong.

Frequently asked

What's the quickest way to tell psoriasis from eczema?

Look at location and edges. Psoriasis favors the outsides of elbows and knees plus the scalp and lower back, with thick silvery scale and sharp, clearly-defined borders. Eczema favors the insides of the elbows and knees, is intensely itchy, and has blurry edges on generally dry skin. Psoriasis often feels sore or burning; eczema is dominated by relentless itch.

How do I know if my facial flaking is seborrheic dermatitis?

Seborrheic dermatitis clusters in oily zones — the scalp, eyebrows, the creases beside the nose, behind the ears, and mid-chest — and produces greasy, yellowish, soft flakes on pink skin rather than thick silvery or dry scale. If flaky redness is riding the sides of your nose and your brows, it's very likely seb derm, which is driven by Malassezia yeast.

Can I use the same treatment for all three conditions?

No, and that's the whole point of telling them apart. Seborrheic dermatitis needs antifungals to target the yeast, eczema needs barrier repair plus anti-inflammatories, and psoriasis often needs vitamin D analogs, targeted steroids, or systemic medication. Using the wrong one can be ineffective or even aggravate the rash — for example, a rich occlusive cream can feed the yeast behind seb derm.

Is psoriasis just a skin condition?

No — psoriasis is a systemic inflammatory disease. The same inflammatory signaling that thickens the skin is linked to higher risks of psoriatic arthritis, cardiovascular events, and metabolic conditions like diabetes, particularly in moderate-to-severe disease. That's a major reason to get it properly diagnosed and managed rather than treating it as a purely cosmetic rash.

When should I stop self-treating a scaly rash and see a dermatologist?

See a professional if the rash is spreading, painfully cracked, accompanied by joint pain, not improving after a couple of weeks of appropriate OTC care, or simply can't be confidently identified. A clinician can confirm which of the three conditions it is and, in the case of psoriasis, evaluate the systemic health picture that a cream can't address.

Not sure where to go next?